Fedders AZ7Y15F2A
million, or a total enterprise value ofabouft $155 million, including net indebtedness. Monogramk is a provider of molecular diagnostic productd that help guide and target appropriate The company’s proprietary Trofile product identifiees patients who are eligible for a class of HIV drugsz and is the widely adopted companiob diagnostic for the HIV drug Selzentry. Other Monogram products identify patients’ resistance to viral drugs, helping doctors desigm individual treatments. “The transaction announcefd today is a significant step in the execution of LabCorp’s strategy of leadership in personalizef medicine,” said David P.
King, chairman and CEO of “By utilizing LabCorp’s national infrastructure to buildon Monogram’ws already strong sales, we will advanc e our leadership in infectious disease and cancer companion diagnostics and personalized medicine. We look forwarrd to providing improved offerings to both ourand Monogram’sd current customers.”
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment